Skip to main content
Top
Published in: Virology Journal 1/2021

Open Access 01-12-2021 | Herpes Virus | Research

Intranasal delivery of plasmids expressing bovine herpesvirus 1 gB/gC/gD proteins by polyethyleneimine magnetic beads activates long-term immune responses in mice

Authors: Xing-Bo Liu, Guo-Wei Yu, Xin-Yu Gao, Jin-Long Huang, Li-Ting Qin, Hong-Bo Ni, Chuang Lyu

Published in: Virology Journal | Issue 1/2021

Login to get access

Abstract

Background

DNA vaccine is one of the research hotspots in veterinary vaccine development. Several advantages, such as cost-effectiveness, ease of design and production, good biocompatibility of plasmid DNA, attractive biosafety, and DNA stability, are found in DNA vaccines.

Methods

In this study, the plasmids expressing bovine herpesvirus 1 (BoHV-1) gB, gC, and gD proteins were mixed at the same mass ratio and adsorbed polyethyleneimine (PEI) magnetic beads with a diameter of 50 nm. Further, the plasmid and PEI magnetic bead polymers were packaged into double carboxyl polyethylene glycol (PEG) 600 to use as a DNA vaccine. The prepared DNA vaccine was employed to vaccinate mice via the intranasal route. The immune responses were evaluated in mice after vaccination.

Results

The expression of viral proteins could be largely detected in the lung and rarely in the spleen of mice subjected to a vaccination. The examination of biochemical indicators, anal temperature, and histology indicated that the DNA vaccine was safe in vivo. However, short-time toxicity was observed. The total antibody detected with ELISA in vaccinated mice showed a higher level than PBS, DNA, PEI + DNA, and PBS groups. The antibody level was significantly elevated at the 15th week and started to decrease since the 17th week. The neutralizing antibody titer was significantly higher in DNA vaccine than naked DNA vaccinated animals. The total IgA level was much greater in the DNA vaccine group compared to other component vaccinated groups. The examination of cellular cytokines and the percentage of CD4/CD8 indicated that the prepared DNA vaccine induced a strong cellular immunity.

Conclusion

The mixed application of plasmids expressing BoHV-1 gB/gC/gD proteins by nano-carrier through intranasal route could effectively activate long-term humoral, cellular, and mucosal immune responses at high levels in mice. These data indicate PEI magnetic beads combining with PEG600 are an efficient vector for plasmid DNA to deliver intranasally as a DNA vaccine candidate.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brisse M, Vrba SM, Kirk N, Liang Y, Ly H. Emerging concepts and technologies in vaccine development. Front Immunol. 2020;11:583077.CrossRef Brisse M, Vrba SM, Kirk N, Liang Y, Ly H. Emerging concepts and technologies in vaccine development. Front Immunol. 2020;11:583077.CrossRef
2.
go back to reference Hobernik D, Bros M. DNA vaccines-how far from clinical use? Int J Mol Sci. 2018;19:3605.CrossRef Hobernik D, Bros M. DNA vaccines-how far from clinical use? Int J Mol Sci. 2018;19:3605.CrossRef
3.
go back to reference Li M, Jiang Y, Xu C, Zhang Z, Sun X. Enhanced immune response against HIV-1 induced by a heterologous DNA prime-adenovirus boost vaccination using mannosylated polyethyleneimine as DNA vaccine adjuvant. Int J Nanomed. 2013;8:1843–54. Li M, Jiang Y, Xu C, Zhang Z, Sun X. Enhanced immune response against HIV-1 induced by a heterologous DNA prime-adenovirus boost vaccination using mannosylated polyethyleneimine as DNA vaccine adjuvant. Int J Nanomed. 2013;8:1843–54.
4.
go back to reference Wiseman JW, Goddard CA, McLelland D, Colledge WH. A comparison of linear and branched polyethylenimine (PEI) with DCChol/DOPE liposomes for gene delivery to epithelial cells in vitro and in vivo. Gene Ther. 2003;10:1654–62.CrossRef Wiseman JW, Goddard CA, McLelland D, Colledge WH. A comparison of linear and branched polyethylenimine (PEI) with DCChol/DOPE liposomes for gene delivery to epithelial cells in vitro and in vivo. Gene Ther. 2003;10:1654–62.CrossRef
5.
go back to reference De Matteis V, Rinaldi R. Toxicity assessment in the nanoparticle era. Adv Exp Med Biol. 2018;1048:1–19.CrossRef De Matteis V, Rinaldi R. Toxicity assessment in the nanoparticle era. Adv Exp Med Biol. 2018;1048:1–19.CrossRef
6.
go back to reference Kulkarni SA, Feng SS. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm Res. 2013;30:2512–22.CrossRef Kulkarni SA, Feng SS. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm Res. 2013;30:2512–22.CrossRef
7.
go back to reference Gustafson HH, Holt-Casper D, Grainger DW, Ghandehari H. Nanoparticle uptake: the phagocyte problem. Nano Today. 2015;10:487–510.CrossRef Gustafson HH, Holt-Casper D, Grainger DW, Ghandehari H. Nanoparticle uptake: the phagocyte problem. Nano Today. 2015;10:487–510.CrossRef
8.
go back to reference Bartneck M, Keul HA, Zwadlo-Klarwasser G, Groll J. Phagocytosis independent extracellular nanoparticle clearance by human immune cells. Nano Lett. 2010;10:59–63.CrossRef Bartneck M, Keul HA, Zwadlo-Klarwasser G, Groll J. Phagocytosis independent extracellular nanoparticle clearance by human immune cells. Nano Lett. 2010;10:59–63.CrossRef
9.
go back to reference Kim MC, Lin MM, Sohn Y, Kim JJ, Kang BS, Kim DK. Polyethyleneimine-associated polycaprolactone-Superparamagnetic iron oxide nanoparticles as a gene delivery vector. J Biomed Mater Res B Appl Biomater. 2017;105:145–54.CrossRef Kim MC, Lin MM, Sohn Y, Kim JJ, Kang BS, Kim DK. Polyethyleneimine-associated polycaprolactone-Superparamagnetic iron oxide nanoparticles as a gene delivery vector. J Biomed Mater Res B Appl Biomater. 2017;105:145–54.CrossRef
10.
go back to reference d’Offay JM, Fulton RW, Fishbein M, Eberle R, Dubovi EJ. Isolation of a naturally occurring vaccine/wild-type recombinant bovine herpesvirus type 1 (BoHV-1) from an aborted bovine fetus. Vaccine. 2019;37:4518–24.CrossRef d’Offay JM, Fulton RW, Fishbein M, Eberle R, Dubovi EJ. Isolation of a naturally occurring vaccine/wild-type recombinant bovine herpesvirus type 1 (BoHV-1) from an aborted bovine fetus. Vaccine. 2019;37:4518–24.CrossRef
11.
go back to reference Gogev S, Vanderheijden N, Lemaire M, Schynts F, D’Offay J, Deprez I, Adam M, Eloit M, Thiry E. Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD. Vaccine. 2002;20:1451–65.CrossRef Gogev S, Vanderheijden N, Lemaire M, Schynts F, D’Offay J, Deprez I, Adam M, Eloit M, Thiry E. Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD. Vaccine. 2002;20:1451–65.CrossRef
12.
go back to reference Gupta PK, Saini M, Gupta LK, Rao VD, Bandyopadhyay SK, Butchaiah G, Garg GK, Garg SK. Induction of immune responses in cattle with a DNA vaccine encoding glycoprotein C of bovine herpesvirus-1. Vet Microbiol. 2001;78:293–305.CrossRef Gupta PK, Saini M, Gupta LK, Rao VD, Bandyopadhyay SK, Butchaiah G, Garg GK, Garg SK. Induction of immune responses in cattle with a DNA vaccine encoding glycoprotein C of bovine herpesvirus-1. Vet Microbiol. 2001;78:293–305.CrossRef
13.
go back to reference Caselli E, Boni M, Di Luca D, Salvatori D, Vita A, Cassai E. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice. Comp Immunol Microbiol Infect Dis. 2005;28:155–66.CrossRef Caselli E, Boni M, Di Luca D, Salvatori D, Vita A, Cassai E. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice. Comp Immunol Microbiol Infect Dis. 2005;28:155–66.CrossRef
14.
go back to reference Sarkinas A, Sakalauskiene K, Raisutis R, Zeime J, Salaseviciene A, Puidaite E, Mockus E, Cernauskas D. Inactivation of some pathogenic bacteria and phytoviruses by ultrasonic treatment. Microb Pathog. 2018;123:144–8.CrossRef Sarkinas A, Sakalauskiene K, Raisutis R, Zeime J, Salaseviciene A, Puidaite E, Mockus E, Cernauskas D. Inactivation of some pathogenic bacteria and phytoviruses by ultrasonic treatment. Microb Pathog. 2018;123:144–8.CrossRef
15.
go back to reference Xiang SD, Selomulya C, Ho J, Apostolopoulos V, Plebanski M. Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010;2:205–18.CrossRef Xiang SD, Selomulya C, Ho J, Apostolopoulos V, Plebanski M. Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010;2:205–18.CrossRef
16.
go back to reference Estelrich J, Sanchez-Martin MJ, Busquets MA. Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents. Int J Nanomed. 2015;10:1727–41. Estelrich J, Sanchez-Martin MJ, Busquets MA. Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents. Int J Nanomed. 2015;10:1727–41.
17.
go back to reference Estelrich J, Escribano E, Queralt J, Busquets MA. Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery. Int J Mol Sci. 2015;16:8070–101.CrossRef Estelrich J, Escribano E, Queralt J, Busquets MA. Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery. Int J Mol Sci. 2015;16:8070–101.CrossRef
18.
go back to reference Sawdon A, Weydemeyer E, Peng CA. Antitumor therapy using nanomaterial-mediated thermolysis. J Biomed Nanotechnol. 2014;10:1894–917.CrossRef Sawdon A, Weydemeyer E, Peng CA. Antitumor therapy using nanomaterial-mediated thermolysis. J Biomed Nanotechnol. 2014;10:1894–917.CrossRef
19.
go back to reference Yu Q, Xiong XQ, Zhao L, Xu TT, Bi H, Fu R, Wang QH. Biodistribution and toxicity assessment of superparamagnetic iron oxide nanoparticles in vitro and in vivo. Curr Med Sci. 2018;38:1096–102.CrossRef Yu Q, Xiong XQ, Zhao L, Xu TT, Bi H, Fu R, Wang QH. Biodistribution and toxicity assessment of superparamagnetic iron oxide nanoparticles in vitro and in vivo. Curr Med Sci. 2018;38:1096–102.CrossRef
20.
go back to reference Al-Deen FN, Ho J, Selomulya C, Ma C, Coppel R. Superparamagnetic nanoparticles for effective delivery of malaria DNA vaccine. Langmuir. 2011;27:3703–12.CrossRef Al-Deen FN, Ho J, Selomulya C, Ma C, Coppel R. Superparamagnetic nanoparticles for effective delivery of malaria DNA vaccine. Langmuir. 2011;27:3703–12.CrossRef
21.
go back to reference Huang Y, Babiuk LA, van Drunen Littel-van den Hurk S. Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle. J Gen Virol. 2005;86:887–98.CrossRef Huang Y, Babiuk LA, van Drunen Littel-van den Hurk S. Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle. J Gen Virol. 2005;86:887–98.CrossRef
22.
go back to reference Mackenzie-Dyck S, Latimer L, Atanley E, Kovacs-Nolan J, Attah-Poku S, Babiuk LA, van Drunen Littel-van den Hurk S. Immunogenicity of a bovine herpesvirus 1 glycoprotein D DNA vaccine complexed with bovine neutrophil beta-defensin 3. Clin Vaccine Immunol. 2015;22:79–90.CrossRef Mackenzie-Dyck S, Latimer L, Atanley E, Kovacs-Nolan J, Attah-Poku S, Babiuk LA, van Drunen Littel-van den Hurk S. Immunogenicity of a bovine herpesvirus 1 glycoprotein D DNA vaccine complexed with bovine neutrophil beta-defensin 3. Clin Vaccine Immunol. 2015;22:79–90.CrossRef
23.
go back to reference Cox GJ, Zamb TJ, Babiuk LA. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol. 1993;67:5664–7.CrossRef Cox GJ, Zamb TJ, Babiuk LA. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol. 1993;67:5664–7.CrossRef
24.
go back to reference Zamorano P, Taboga O, Dominguez M, Romera A, Puntel M, Tami C, Mongini C, Waldner C, Palma E, Sadir A. BHV-1 DNA vaccination: effect of the adjuvant RN-205 on the modulation of the immune response in mice. Vaccine. 2002;20:2656–64.CrossRef Zamorano P, Taboga O, Dominguez M, Romera A, Puntel M, Tami C, Mongini C, Waldner C, Palma E, Sadir A. BHV-1 DNA vaccination: effect of the adjuvant RN-205 on the modulation of the immune response in mice. Vaccine. 2002;20:2656–64.CrossRef
25.
go back to reference Takashima Y, Nagane N, Hushur O, Matsumoto Y, Otsuka H. Bovine herpesvirus-1 (BHV-1) recombinant expressing pseudorabies virus (PrV) glycoproteins B and C induces type 1 immune response in BALB/c mice. J Vet Med Sci. 2002;64:589–96.CrossRef Takashima Y, Nagane N, Hushur O, Matsumoto Y, Otsuka H. Bovine herpesvirus-1 (BHV-1) recombinant expressing pseudorabies virus (PrV) glycoproteins B and C induces type 1 immune response in BALB/c mice. J Vet Med Sci. 2002;64:589–96.CrossRef
26.
go back to reference Fleck JD, Kauffmann C, Spilki F, Lencina CL, Roehe PM, Gosmann G. Adjuvant activity of Quillaja brasiliensis saponins on the immune responses to bovine herpesvirus type 1 in mice. Vaccine. 2006;24:7129–34.CrossRef Fleck JD, Kauffmann C, Spilki F, Lencina CL, Roehe PM, Gosmann G. Adjuvant activity of Quillaja brasiliensis saponins on the immune responses to bovine herpesvirus type 1 in mice. Vaccine. 2006;24:7129–34.CrossRef
27.
go back to reference Loehr BI, Willson P, Babiuk LA, van Drunen Littel-van den Hurk S. Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle. J Virol. 2000;74:6077–86.CrossRef Loehr BI, Willson P, Babiuk LA, van Drunen Littel-van den Hurk S. Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle. J Virol. 2000;74:6077–86.CrossRef
Metadata
Title
Intranasal delivery of plasmids expressing bovine herpesvirus 1 gB/gC/gD proteins by polyethyleneimine magnetic beads activates long-term immune responses in mice
Authors
Xing-Bo Liu
Guo-Wei Yu
Xin-Yu Gao
Jin-Long Huang
Li-Ting Qin
Hong-Bo Ni
Chuang Lyu
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2021
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-021-01536-w

Other articles of this Issue 1/2021

Virology Journal 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.